+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Oxidative metabolism of koumine is mainly catalyzed by microsomal CYP3A4/3A5



Oxidative metabolism of koumine is mainly catalyzed by microsomal CYP3A4/3A5



Xenobiotica; the Fate of Foreign Compounds in Biological Systems 47(7): 584-591



1. Gelsemium elegans Benth (Loganiaceae) is a toxic plant that can be used for committing suicide besides alleviating pains. Its anti-inflammatory and analgesic effect mainly come from its active ingredient, namely koumine. Koumine, an indole alkaloid, possesses widely pharmacological effects especially inhibition of neuropathic pain. 2. This study aimed to investigate the metabolic profile of koumine using human liver microsomes (HLMs), selective chemical inhibitors and recombinant human CYP isoforms. Ultra-performance liquid chromatography-high-resolution mass spectrometry (UPLC-HRMS) was used to detect and identify metabolites. 3. Four major metabolites of koumine were found after incubation with HLMs or individual CYP isoforms. The metabolic pathways of koumine included demethylation, dehydrogenation, oxidation and demethyl-dehydrogenation. Chemical inhibition study showed that the inhibitor of CYP3A4/3A5 significantly decreased (93%) the formation of koumine metabolites. Further, CYP3A4/3A5 was shown as the most efficient isoform in biotransformation of koumine, among a series of CYP isoforms tested. 4. In conclusion, koumine was metabolized into four oxidative metabolites in HLMs. And CYP3A4/3A5 was probably the main contributor to the hepatic oxidative metabolism of koumine.

(PDF emailed within 0-6 h: $19.90)

Accession: 058488789

Download citation: RISBibTeXText

PMID: 27499416

DOI: 10.1080/00498254.2016.1213925


Related references

Reductive metabolism of oxymatrine is catalyzed by microsomal CYP3A4. Drug Design, Development and Therapy 9: 5771-5783, 2016

CYP3A4 expressed by insect cells infected with a recombinant baculovirus containing both CYP3A4 and human NADPH-cytochrome P450 reductase is catalytically similar to human liver microsomal CYP3A4. Archives Of Biochemistry & Biophysics. 319(1): 157-167, 1995

Covalent modification of CYP3A4 protein during microsomal metabolism of ritonavir. Drug Metabolism Reviews 35(Supplement 2): 107, 2003

Evaluation of microsomal incubation conditions on CYP3A4-mediated metabolism of cyclosporine A by a statistical experimental design. Current Drug Metabolism 7(3): 265-271, 2006

CYP3A4 Mediates Oxidative Metabolism of the Synthetic Cannabinoid AKB-48. Aaps Journal 17(5): 1237-1245, 2016

Inhibition of CYP3A4 and CYP3A5 catalyzed metabolism of alprazolam and quinine by ketoconazole as racemate and four different enantiomers. European Journal of Clinical Pharmacology 63(2): 173-179, 2007

Dirlotapide as a model substrate to refine structure-based drug design strategies on CYP3A4-catalyzed metabolism. Bioorganic and Medicinal Chemistry Letters 22(1): 371-376, 2012

Flunitrazepam oxidative metabolism in human liver microsomes: involvement of CYP2C19 and CYP3A4. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 29(10): 973-986, 1999

CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes. British Journal of Clinical Pharmacology 57(3): 287-297, 2004

Development of mice exhibiting hepatic microsomal activity of human CYP3A4 comparable to that in human liver microsomes by intravenous administration of an adenovirus vector expressing human CYP3A4. Drug Metabolism and Pharmacokinetics 29(4): 296-304, 2015

Impairment of CYP3A4 capacity in patients receiving danazol therapy: examination on oxidative cortisol metabolism. Hormone and Metabolic Research 33(10): 628-630, 2001

Biomimetic synthesis of koumine by the palladium catalyzed intramolecular coupling reaction of 18 hydroxytaberpsychine 18 hydroxyanhydrovobasinediol. Heterocycles (Tokyo) 30(1): 325-328, 1990

CYP2B6, CYP2D6, and CYP3A4 catalyze the primary oxidative metabolism of perhexiline enantiomers by human liver microsomes. Drug Metabolism and Disposition: the Biological Fate of Chemicals 35(1): 128-138, 2006

Human variability in CYP3A4 metabolism and CYP3A4-related uncertainty factors for risk assessment. Food & Chemical Toxicology 41(2): 201-224, February, 2003